Pharmacokinetics of transdermal drug deliveryBERNER, B.Journal of pharmaceutical sciences. 1985, Vol 74, Num 7, pp 718-721, issn 0022-3549Article

Problems associated with the extraction and analysis of triamcinolone acetonide in dermatological patchesEDWARDSON, P. A. D; GARDNER, R. S.Journal of pharmaceutical and biomedical analysis. 1990, Vol 8, Num 8-12, pp 935-938, issn 0731-7085, 4 p.Conference Paper

Efficacy of transdermal scopolamine against seasickness: a 3-day study at seaATTIAS, J; GORDON, C; RIBAK, J et al.Aviation, space, and environmental medicine. 1987, Vol 58, Num 1, pp 60-62, issn 0095-6562Article

Transdermal drug deliveryPRAUSNITZ, Mark R; LANGER, Robert.Nature biotechnology (Print). 2008, Vol 26, Num 11, issn 1087-0156, 1261-1268 [8 p.]Article

Delayed hypersensitivity to scopolamine delivered by a transdermal deviceTROZAK, D. J.Journal of the American Academy of Dermatology. 1985, Vol 13, Num 2, pp 247-251, issn 0190-9622Article

Classification of percutaneous penetration enhancers: a conceptional diagramHORI, M; SATOH, S; MAIBACH, H. I et al.Journal of pharmacy and pharmacology. 1990, Vol 42, Num 1, pp 71-72, issn 0022-3573, 2 p.Article

Approaches for breaking the barriers of drug permeation through transdermal drug deliveryALEXANDER, Amit; DWIVEDI, Shubhangi; AJAZUDDIN et al.Journal of controlled release. 2012, Vol 164, Num 1, pp 26-40, issn 0168-3659, 15 p.Article

Release Liner Removal Method For Transdermal Drug Delivery Systems (TDDS)WOKOVICH, Anna M; MEIYU SHEN; DOUB, William H et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 7, pp 3177-3187, issn 0022-3549, 11 p.Article

Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain : A multicenter, open-label, uncontrolled, prospective, observational clinical studyMURIEL, Clemente; FAILDE, Inmaculada; MICO, Juan A et al.Clinical therapeutics. 2005, Vol 27, Num 4, pp 451-462, issn 0149-2918, 12 p.Article

Content uniformity acceptance limit for a validation batch―suppositories, transdermal systems, and inhalationsSENDERAK, Edith T.Drug development and industrial pharmacy. 2009, Vol 35, Num 6, pp 735-737, issn 0363-9045, 3 p.Article

An asymptotic analysis of drug delivery from transdermal patchesOSBORNE, J. L; SANCHEZ, I. C; PAUL, D. R et al.Journal of membrane science (Print). 2013, Vol 442, pp 27-38, issn 0376-7388, 12 p.Article

Microemulsions as transdermal drug delivery vehiclesKOGAN, Anna; GARTI, Nissim.Advances in colloid and interface science. 2006, Vol 123-26, pp 369-385, issn 0001-8686, 17 p.Article

Double blind trial of repeated treatment with transdermal nicotine for relapsed smokersGOURLAY, S. G; FORBES, A; MARRINER, T et al.BMJ. British medical journal (International ed.). 1995, Vol 311, Num 7001, pp 363-366, issn 0959-8146Article

Transdermal nicotine for smoking cessation : Emerging therapies for respiratory disordersRENNARD, S. I; DAUGHTON, D.Respiratory care. 1993, Vol 38, Num 3, pp 290-293, issn 0020-1324Conference Paper

Membrane-controlled transdermal therapeutic system containing clonazepam and anticonvulsant activity after its applicationOGISO, T; ITO, Y; IWAKI, M et al.Chemical and pharmaceutical bulletin. 1989, Vol 37, Num 2, pp 446-449, issn 0009-2363, 4 p.Article

Transdermal delivery of drugs for urologic applications : Basic principles and applicationsNITTI, Victor W; SANDERS, Steven; STASKIN, David R et al.Urology (Ridgewood, NJ). 2006, Vol 67, Num 4, pp 657-664, issn 0090-4295, 8 p.Article

Pharmacokinetic analysis of plasma drug level data obtained from a transdermal therapeutic system with a complex absorption modelTAKADA, K; YOSHIKAWA, H; MURANISHI, S et al.International journal of pharmaceutics. 1990, Vol 65, Num 3, pp 159-167, issn 0378-5173, 9 p.Article

Transdermally administered scopolamine vs. dimenhydrinate. II: Effect on different types of nystagmusPYYKKO, I; SCHALEN, L; MATSUOKA, I et al.Acta oto-laryngologica. 1985, Vol 99, Num 5-6, pp 597-604, issn 0001-6489Article

The transdermal contraceptive systemBURKMAN, Ronald T.American journal of obstetrics and gynecology. 2004, Vol 190, Num 4, pp S49-S53, issn 0002-9378, SUPArticle

Le passage percutané des médicaments : Les dispositifs transdermiques = Percutaneous passage of drugs : transdermal delivery systemsZUBER, M; ARNAUD, P.La Semaine des hôpitaux de Paris. 1996, Vol 72, Num 13-14, pp 409-420, issn 0037-1777Article

New potential uses for transdermal scopolamine (hyoscine)LA ROVERE, M. T; DE FERRARI, G. M.Drugs (Basel). 1995, Vol 50, Num 5, pp 769-776, issn 0012-6667Article

Aspects of the transdermal delivery of prostaglandins IIWATKINSON, A. C; BUNGE, A. L; HADGRAFT, J et al.International journal of pharmaceutics. 1992, Vol 83, Num 1-3, pp 171-175, issn 0378-5173Article

Hemodynamics and serum nitroglycerin concentration during intraoperative use of nitroglycerin patchesSAITOH, K; ISHII, R; SHIMIZU, R et al.Masui. 1992, Vol 41, Num 12, pp 1889-1893, issn 0021-4892Article

Clonidine transdermal patch poisoningCARAVATI, E. M; BENNETT, D. L.Annals of emergency medicine. 1988, Vol 17, Num 2, pp 175-176, issn 0196-0644Article

Skin penetration revisitedRIEGER, M.Cosmetics and toiletries. 1988, Vol 103, Num 2, pp 69-76, issn 0361-4387, 6 p.Article